New biomarkers could prevent unnecessary surgeries for pancreatic cysts

NCT ID NCT06574373

Recruiting now Knowledge-focused Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times

Summary

This study looks for biological markers in people with pancreatic cysts (IPMN) to better predict which ones are likely to become cancer. By analyzing tissue and blood samples from 3,600 participants, researchers hope to improve risk assessment and guide personalized treatment. The goal is to reduce unnecessary surgeries for low-risk patients while catching high-risk cases earlier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IPMN, PANCREATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fondazione Policlinico Gemelli
RECRUITING

Roma, 00168, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
IRCCS Fondazione Policlinico Universitario A. Gemelli
NOT_YET_RECRUITING

Rome, 00168, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

IPMN, PANCREATIC